Found: 33
Select item for more details and to access through your institution.
Control of recombinant human endostatin production in fed-batch cultures of Pichia pastoris using the methanol feeding rate.
- Published in:
- Biotechnology Letters, 2002, v. 24, n. 19, p. 1631, doi. 10.1023/A:1020357732474
- By:
- Publication type:
- Article
Keratinocyte Growth Factor: A Fibroblast Growth Factor Family Member with Unusual Target Cell Specificity.
- Published in:
- Annals of the New York Academy of Sciences, 1991, v. 638, n. 1, p. 62, doi. 10.1111/j.1749-6632.1991.tb49018.x
- By:
- Publication type:
- Article
Combination therapy with pazopanib and tivantinib modulates VEGF and c-MET levels in refractory advanced solid tumors.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 6, p. 1577, doi. 10.1007/s10637-021-01138-x
- By:
- Publication type:
- Article
Absolute Quantitation of Met Using Mass Spectrometry for Clinical Application: Assay Precision, Stability, and Correlation with <i>MET</i> Gene Amplification in FFPE Tumor Tissue.
- Published in:
- PLoS ONE, 2014, v. 9, n. 7, p. 1, doi. 10.1371/journal.pone.0100586
- By:
- Publication type:
- Article
Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer.
- Published in:
- PLoS ONE, 2013, v. 8, n. 3, p. 1, doi. 10.1371/journal.pone.0054014
- By:
- Publication type:
- Article
Heparin Inhibits Hepatocyte Growth Factor Induced Motility and Invasion of Hepatocellular Carcinoma Cells through Early Growth Response Protein 1.
- Published in:
- PLoS ONE, 2012, v. 7, n. 8, p. 1, doi. 10.1371/journal.pone.0042717
- By:
- Publication type:
- Article
Molecular Signaling in Bioengineered Tissue Microenvironments.
- Published in:
- Annals of the New York Academy of Sciences, 2002, v. 961, n. 1, p. 143, doi. 10.1111/j.1749-6632.2002.tb03068.x
- By:
- Publication type:
- Article
The Role of Extracellular Matrix Heparan Sulfate Glycosaminoglycan in the Activation of Growth Factor Signaling Pathways.
- Published in:
- Annals of the New York Academy of Sciences, 2002, v. 961, n. 1, p. 158, doi. 10.1111/j.1749-6632.2002.tb03071.x
- By:
- Publication type:
- Article
Mitogenic synergy through multilevel convergence of hepatocyte growth factor and interleukin-4 signaling pathways.
- Published in:
- Oncogene, 2002, v. 21, n. 14, p. 2201, doi. 10.1038/sj.onc.1205289
- By:
- Publication type:
- Article
Rilotumumab Resistance Acquired by Intracrine Hepatocyte Growth Factor Signaling.
- Published in:
- Cancers, 2023, v. 15, n. 2, p. 460, doi. 10.3390/cancers15020460
- By:
- Publication type:
- Article
Regression of Human Breast Carcinoma in Nude Mice after Ad sflt Gene Therapy Is Mediated by Tumor Vascular Endothelial Cell Apoptosis.
- Published in:
- Cancers, 2022, v. 14, n. 24, p. 6175, doi. 10.3390/cancers14246175
- By:
- Publication type:
- Article
Characterization of HGF/Met Signaling in Cell Lines Derived From Urothelial Carcinoma of the Bladder.
- Published in:
- Cancers, 2014, v. 6, n. 4, p. 2313, doi. 10.3390/cancers6042313
- By:
- Publication type:
- Article
Correction: Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Autocrine signaling by receptor tyrosine kinases in urothelial carcinoma of the bladder.
- Published in:
- PLoS ONE, 2021, v. 16, n. 7, p. 1, doi. 10.1371/journal.pone.0241766
- By:
- Publication type:
- Article
Hyperphosphorylation and increased proteolytic breakdown of c-Myb induced by the inhibition of Ser/Thr protein phosphatases.
- Published in:
- Oncogene, 2000, v. 19, n. 24, p. 2846, doi. 10.1038/sj.onc.1203613
- By:
- Publication type:
- Article
Neu differentiation factor/heregulin induction by hepatocyte and keratinocyte growth factors.
- Published in:
- Oncogene, 2000, v. 19, n. 5, p. 640, doi. 10.1038/sj.onc.1203357
- By:
- Publication type:
- Article
Differential signaling by alternative HGF isoforms through c-Met: activation of both MAP kinase and PI 3-kinase pathways is insufficient for mitogenesis.
- Published in:
- Oncogene, 1999, v. 18, n. 22, p. 3399, doi. 10.1038/sj.onc.1202683
- By:
- Publication type:
- Article
Induction of tissue inhibitor of metalloproteinases-3 is a delayed early cellular response to hepatocyte growth factor.
- Published in:
- Oncogene, 1998, v. 17, n. 4, p. 481, doi. 10.1038/sj.onc.1201957
- By:
- Publication type:
- Article
A novel human ERK phosphatase regulates H-ras and v-raf signal transduction.
- Published in:
- Oncogene, 1997, v. 14, n. 22, p. 2633, doi. 10.1038/sj.onc.1201106
- By:
- Publication type:
- Article
Gab1 mediates hepatocyte growth factor-stimulated mitogenicity and morphogenesis in multipotent myeloid cells.
- Published in:
- Journal of Cellular Biochemistry, 2010, v. 111, n. 2, p. 310, doi. 10.1002/jcb.22695
- By:
- Publication type:
- Article
Immuno-PET of the Hepatocyte Growth Factor Receptor Met Using the 1-Armed Antibody Onartuzumab.
- Published in:
- Journal of Nuclear Medicine, 2012, v. 53, n. 10, p. 1592, doi. 10.2967/jnumed.111.102293
- By:
- Publication type:
- Article
Cancer: Out of air is not out of action.
- Published in:
- Nature, 2003, v. 423, n. 6940, p. 593, doi. 10.1038/423593a
- By:
- Publication type:
- Article
Tumor and Plasma Met Levels in Non-Metastatic Prostate Cancer.
- Published in:
- PLoS ONE, 2016, v. 11, n. 6, p. 1, doi. 10.1371/journal.pone.0157130
- By:
- Publication type:
- Article
Stable Ectopic Expression of ST6GALNAC5 Induces Autocrine MET Activation and Anchorage-Independence in MDCK Cells.
- Published in:
- PLoS ONE, 2016, v. 11, n. 2, p. 1, doi. 10.1371/journal.pone.0148075
- By:
- Publication type:
- Article
Preliminary evaluation of urinary soluble Met as a biomarker for urothelial carcinoma of the bladder.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Application of ring-closing metathesis to Grb2 SH3 domain-binding peptides.
- Published in:
- Biopolymers, 2011, v. 96, n. 6, p. 780, doi. 10.1002/bip.21692
- By:
- Publication type:
- Article
Correction: Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Inhibition of HSP 90 is associated with potent anti-tumor activity in Papillary Renal Cell Carcinoma.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02416-z
- By:
- Publication type:
- Article
Novel antibody reagents for characterization of drug- and tumor microenvironment-induced changes in epithelial-mesenchymal transition and cancer stem cells.
- Published in:
- PLoS ONE, 2018, v. 13, n. 6, p. 1, doi. 10.1371/journal.pone.0199361
- By:
- Publication type:
- Article
Hepatocyte growth factor/ MET in cancer progression and biomarker discovery.
- Published in:
- Cancer Science, 2017, v. 108, n. 3, p. 296, doi. 10.1111/cas.13156
- By:
- Publication type:
- Article
0.2 T magnetic field inhibits angiogenesis in chick embryo chorioallantoic membrane.
- Published in:
- Bioelectromagnetics, 2004, v. 25, n. 5, p. 390, doi. 10.1002/bem.20008
- By:
- Publication type:
- Article
Imaging the Met Receptor Tyrosine Kinase (Met) and Assessing Tumor Responses to a Met Tyrosine Kinase Inhibitor in Human Xenograft Mouse Models with a [<sup>99m</sup>Tc] (AH-113018) or Cy 5<sup>**</sup> (AH-112543) Labeled Peptide.
- Published in:
- Molecular Imaging, 2015, v. 14, p. 499, doi. 10.2310/7290.2015.00023
- By:
- Publication type:
- Article
Imaging the Met Receptor Tyrosine Kinase (Met) and Assessing Tumor Responses to a Met Tyrosine Kinase Inhibitor in Human Xenograft Mouse Models with a [<sup>99m</sup>Tc] (AH-113018) or Cy 5** (AH-112543) Labeled Peptide.
- Published in:
- Molecular Imaging, 2015, v. 14, p. 499, doi. 10.2310/7290.2015.00023
- By:
- Publication type:
- Article